mirabegron

Spain

Drugs containing this active substance

  • BETMIGA 50 MG PROLONGED-RELEASE TABLETS

    It is used to treat the symptoms of an overactive bladder in adults (such as a sudden urge to urinate, going to the bathroom more often than normal, or being unable to control the release of urine) and to treat neurogenic detrusor overactivity in children between 3 and under 18 years of age.

    Form: tablets, prolonged-release

    Active substance Dosage
    mirabegron 50 mg

    ATC: G04B G04BD G04BD12

    Manufacturer: Astellas Pharma Europe B.V.